Metraipolis › archive › dc_32096f654662

Optimizing Lenvatinib Therapy for Prognostic Improvement in Advanced Thyroid Cancer — Europe PMC PMID:41155549

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41155549
DOI: 10.3390/ph18101432
License (as archived): solo-consultazione
Archived: 2026-11-09T19:12:44.245Z
SHA-256 of the archived text: 71f53f542be0709d00a290269269cedc728fb97ed5aaabe0690f3cb3a66e23eb
Stable URL of this page: https://metraipolis.com/documento/dc_32096f654662

How to cite

Optimizing Lenvatinib Therapy for Prognostic Improvement in Advanced Thyroid Cancer — Europe PMC PMID:41155549 — Europe PMC (en), https://europepmc.org/article/MED/41155549 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32096f654662 (Metraipolis archive dc_32096f654662, sha256 71f53f542be0709d00a290269269cedc728fb97ed5aaabe0690f3cb3a66e23eb)

BibTeX

@misc{dc32096f654662,
  title = {Optimizing Lenvatinib Therapy for Prognostic Improvement in Advanced Thyroid Cancer — Europe PMC PMID:41155549},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155549},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32096f654662; sha256 71f53f542be0709d00a290269269cedc728fb97ed5aaabe0690f3cb3a66e23eb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155549. Agents can read the archived copy with the MCP tool read_document.